Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-08

Clinical Trial Update: Urine Interleukin-37 as a Biomarker of Mortality Risk in Patients With Sepsis

View source ↗

Summary

A completed trial assessing whether urine interleukin-37 can predict mortality risk in sepsis patients. The study reports results on IL-37 as a prognostic bioma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Zhongnan Hospital | Conditions: Sepsis | Status: COMPLETED